Moxifloxacin 400 mg
(3rd generation fluoroquinolones).


  • Community Acquired Pneumonia.
  • Skin and skin structure infections.
  • Intra-abdominal infections (Included in H. Pylori Regimen).
  • Plague.
  • Acute Bacterial Sinusitis.
  • Acute Bacterial Exacerbation of Chronic Bronchitis
  • Odontogenic infection.

Why Moxavidex?

  • Covers (G +ve, G -ve bacteria), and it is the most active fluoroquinolones against anaerobes.
  • Recommended by "Infectious Diseases Society of America" guidelines in skin and skin structure, intra-abdominal and diabetic foot infections.
  • Respectively as initial empirical monotherapy.
  • Recommended by "The Japanese Society of Gastroenterology" in treatment of H.pylori (evidence level A). 

Dose                                    1 Tablet Once Daily
Box                                        1 Strips Each strip contains 5 Tablets

Antiinfectives for Systemic use
Download Leaflet: